Delivery Order SPE2DB25D3306-SPE2DB26FUAPH
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $16,927.84 to AmerisourceBergen Drug Corp for the supply of Eliquis 5 mg tablets (60-count units) on October 29, 2025, with an ultimate completion date of October 30, 2025. This competitively awarded, non-set-aside contract represents a firm fixed-price delivery order utilizing AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical. The order will be fulfilled from the vendor's facility in...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on October 24, 2025, for the supply of Eliquis 5 mg tablets (60-count packages) with a contract value of $2,491.80. This is a firm fixed price delivery order with an ultimate completion date of October 27, 2025, and represents a non-competitive set-aside award. AmerisourceBergen will perform this work from its corporate headquarters in Conshohocken, Pennsylvania, where the company maintains operations as a major...
- The Defense Logistics Agency awarded a $25,827.06 delivery order to AmerisourceBergen Drug Corp on August 12, 2025, for the supply of Eliquis 5 mg tablets in quantities of 60 per package. This is a firm fixed price, competitively awarded contract with no set-aside designation and an ultimate completion date of August 13, 2025. The order will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains its primary headquarters and...
- The Defense Logistics Agency awarded a delivery order valued at $1,719.90 to AmerisourceBergen Drug Corp for the supply of Eliquis 5 mg tablets (60-count units) on August 6, 2025, with completion scheduled for August 7, 2025. This is a firm fixed price delivery order with no set-aside designation, indicating it was competitively awarded. The product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under the...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a firm fixed-price delivery order to AmerisourceBergen Drug Corp on August 7, 2025, for the supply of Eliquis 5 mg tablets (60-count packages) with a ceiling value of $18,978.90. This non-set-aside competitive award is scheduled for completion by August 8, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a single transaction under the company's...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $16,478.85 for 60 tablets of Eliquis 5 mg on August 13, 2025, with completion scheduled for August 14, 2025. This non-competitive, firm fixed-price delivery order represents a routine pharmaceutical supply transaction fulfilling military healthcare needs. The place of performance is located at AmerisourceBergen's corporate headquarters in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order valued at approximately $29.5K to AmerisourceBergen Drug Corp for the supply of Eliquis 5 mg tablets (60-count units) on September 22, 2025, with completion expected by September 23, 2025. This is a firm fixed price delivery order with no set-aside designation, indicating the award was competitively procured. The pharmaceutical product will be delivered to AmerisourceBergen's corporate headquarters location in Conshohocken, Pennsylvania,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Eliquis 5 mg tablets (60-count packages) valued at $16,636.35 under a firm fixed-price contract. The award was made on August 25, 2025, with an ultimate completion date of August 26, 2025, and represents a non-set-aside competitive procurement. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, will perform the delivery of this pharmaceutical product from its corporate office...
- The Defense Logistics Agency awarded a delivery order valued at $1,228.50 to AmerisourceBergen Drug Corp for the supply of Eliquis 2.5 mg tablets (60-count packages) on September 25, 2025. The contract represents a firm fixed-price delivery order with an ultimate completion date of September 26, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. This award was competitively awarded with no set-aside designation applied. This delivery order is...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 25, 2025, for the supply of Eliquis 5 mg tablets (60-count units) valued at $36,722.05. This firm fixed-price delivery order, with an ultimate completion date of August 26, 2025, represents a competitive award with no set-aside designation. The order will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains its headquarters as a...
- SPE2DB25D3306Indefinite Delivery Contract
- SPE2DB25D3306-SPE2DB26FUAPHDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $13,815.81 to AmerisourceBergen Drug Corp for the supply of Eliquis 5 mg tablets (60-count packages) on November 3, 2025, with an ultimate completion date of November 4, 2025. This is a firm fixed-price delivery order with no set-aside designation, indicating competitive award of the pharmaceutical product. The place of performance is listed as AmerisourceBergen's corporate headquarters in Conshohocken, Pennsylvania, where the company maintains its primary distribution operations for federal medical procurement. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (SPE2DX) with DLA Troop Support Medical, a $999.999 billion global pharmaceutical support vehicle running through December 2026. As a major pharmaceutical distributor, AmerisourceBergen supplies a comprehensive range of medications, vaccines, and medical supplies to support military healthcare programs worldwide. Eliquis, an anticoagulant medication, represents part of the company's extensive pharmaceutical portfolio delivered through the DLA Medical Supply Chain to support Defense Health Agency, U.S. Coast Guard, and other government healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $13.8k | 11/3/25 |